Shypd.aiThe largest open index of AI toolsAbsci is a clinical-stage biopharmaceutical company that advances innovative therapeutics with generative AI. It designs differentiated biologics against challenging targets using its AI Drug Creation Platform.
Trending
About
Absci is a clinical-stage biopharmaceutical company leveraging generative AI to advance innovative therapeutics. Its Integrated AI Drug Creation Platform combines wet lab and AI in iterative cycles to build AI models that unlock differentiated biology and design better biologics faster. This platform enables de novo design of biologics, multi-parametric lead optimization, and AI-enabled novel target discovery using Reverse Immunology. Absci aims to accelerate biologics discovery and create life-changing medicines for patients by designing differentiated antibodies, such as ABS-201 for androgenetic alopecia, and bringing them from concept to clinical trial pipeline in 24 months.
Capabilities
Pricing & Plans
Likely Not Free
Not publicly disclosed. Check absci.com for current pricing.
FAQs
Trending
